[1]
K. V. KUMARI, M. K. FATIMA, F. SULTANA, C. T., and M. M. QUADRI, “A STUDY TO EVALUATE THE EFFECT OF EMPAGLIFLOZIN ON CARDIOVASCULAR AND RENAL OUTCOMES OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AT A TERTIARY CARE HOSPITAL, IN TELANGANA”, Int J Pharm Pharm Sci, vol. 17, no. 3, Feb. 2025.